NO20015635L - Mikroseriebasert subtraktiv hybridisering - Google Patents

Mikroseriebasert subtraktiv hybridisering

Info

Publication number
NO20015635L
NO20015635L NO20015635A NO20015635A NO20015635L NO 20015635 L NO20015635 L NO 20015635L NO 20015635 A NO20015635 A NO 20015635A NO 20015635 A NO20015635 A NO 20015635A NO 20015635 L NO20015635 L NO 20015635L
Authority
NO
Norway
Prior art keywords
identification
removal
nucleic acids
present
library
Prior art date
Application number
NO20015635A
Other languages
English (en)
Other versions
NO330813B1 (no
NO20015635D0 (no
Inventor
Steven Perrin
Katherine Call
Timothy Connolly
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20015635D0 publication Critical patent/NO20015635D0/no
Publication of NO20015635L publication Critical patent/NO20015635L/no
Publication of NO330813B1 publication Critical patent/NO330813B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20015635A 1999-05-19 2001-11-19 Fremgangsmate for a analysere en heterolog nukleinsyrepopulasjon NO330813B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/314,698 US6638717B2 (en) 1999-05-19 1999-05-19 Microarray-based subtractive hybridzation
PCT/US2000/013789 WO2000070098A1 (en) 1999-05-19 2000-05-19 Microarray-based subtractive hybridization

Publications (3)

Publication Number Publication Date
NO20015635D0 NO20015635D0 (no) 2001-11-19
NO20015635L true NO20015635L (no) 2002-01-15
NO330813B1 NO330813B1 (no) 2011-07-25

Family

ID=23221053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015635A NO330813B1 (no) 1999-05-19 2001-11-19 Fremgangsmate for a analysere en heterolog nukleinsyrepopulasjon

Country Status (18)

Country Link
US (1) US6638717B2 (no)
EP (1) EP1185699B1 (no)
JP (1) JP4714883B2 (no)
KR (1) KR100733930B1 (no)
AT (1) ATE382097T1 (no)
AU (1) AU779901B2 (no)
BR (1) BR0011297A (no)
CA (1) CA2372698C (no)
CY (1) CY1107428T1 (no)
DE (1) DE60037584T2 (no)
DK (1) DK1185699T3 (no)
ES (1) ES2296623T3 (no)
IL (2) IL146547A0 (no)
MX (1) MXPA01011730A (no)
NO (1) NO330813B1 (no)
PT (1) PT1185699E (no)
WO (1) WO2000070098A1 (no)
ZA (1) ZA200109609B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272056A1 (en) * 1996-11-13 2005-12-08 Deiss Louis P Gene identification method
US20020142341A1 (en) * 2001-03-28 2002-10-03 Makoto Kameyama Method and apparatus for producing probe carrier
US20040110153A1 (en) * 2002-12-10 2004-06-10 Affymetrix, Inc. Compleixity management of genomic DNA by semi-specific amplification
JP4182338B2 (ja) * 2003-03-06 2008-11-19 信越化学工業株式会社 熱硬化性パーフルオロポリエーテル系ゴム組成物及びゴム製品
US7300755B1 (en) * 2003-05-12 2007-11-27 Fred Hutchinson Cancer Research Center Methods for haplotyping genomic DNA
US20050075712A1 (en) 2003-10-06 2005-04-07 Brian Biancucci Minimally invasive valve replacement system
EP2290071B1 (en) 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
EP2281888B1 (en) 2004-11-12 2015-01-07 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
EP2145001A2 (en) 2006-09-19 2010-01-20 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
AU2007299828C1 (en) 2006-09-19 2014-07-17 Interpace Diagnostics, Llc MicroRNAs differentially expressed in pancreatic diseases and uses thereof
GB0618514D0 (en) * 2006-09-20 2006-11-01 Univ Nottingham Trent Method of detecting interactions on a microarray using nuclear magnetic resonance
US8716190B2 (en) 2007-09-14 2014-05-06 Affymetrix, Inc. Amplification and analysis of selected targets on solid supports
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
JP5221248B2 (ja) * 2008-08-26 2013-06-26 株式会社日立ハイテクノロジーズ 高発現遺伝子由来のｃＤＮＡクローンの含有率を低減させたｃＤＮＡライブラリーの作製方法
US20100331204A1 (en) * 2009-02-13 2010-12-30 Jeff Jeddeloh Methods and systems for enrichment of target genomic sequences
US20110059453A1 (en) * 2009-08-23 2011-03-10 Affymetrix, Inc. Poly(A) Tail Length Measurement by PCR
EP3214174B1 (en) 2010-03-04 2019-10-16 InteRNA Technologies B.V. A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt
AU2011274619B2 (en) 2010-07-06 2016-11-10 Interna Technologies Bv miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
EP2640851A2 (en) 2010-11-17 2013-09-25 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
CA2828532A1 (en) 2011-02-28 2012-11-22 University Of Iowa Research Foundation Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
EP2705153A1 (en) 2011-05-02 2014-03-12 Pioneer Hi-Bred International, Inc. Bacterial mrna screen strategy for novel pesticide-encoding nucleic acid molecule discovery
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
WO2014007623A1 (en) 2012-07-03 2014-01-09 Interna Technologies B.V. Diagnostic portfolio and its uses
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
WO2014144666A2 (en) 2013-03-15 2014-09-18 The University Of Chicago Methods and compositions related to t-cell activity
CA2907377A1 (en) 2013-03-15 2014-09-18 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
EP2971149B1 (en) 2013-03-15 2018-05-09 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
KR101516976B1 (ko) * 2013-10-30 2015-05-04 에스케이텔레콤 주식회사 표적 염기 서열 해독에서의 바이어스 제거 방법
CN111566212A (zh) 2017-11-03 2020-08-21 因特尔纳技术有限公司 miRNA分子，等同物，安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
CN113924085A (zh) 2019-04-12 2022-01-11 加利福尼亚大学董事会 用于增加肌肉量和氧化代谢的组合物和方法
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5591575A (en) 1993-04-07 1997-01-07 Amersham International Plc Subtraction hybridization employing aziridinylbenoquinone cross-linking agents
US5482845A (en) 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5728529A (en) 1995-06-23 1998-03-17 Baylor College Of Medicine Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis
US5851772A (en) 1996-01-29 1998-12-22 University Of Chicago Microchip method for the enrichment of specific DNA sequences
US5712127A (en) 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
US5827658A (en) 1996-08-09 1998-10-27 The United States Of America As Reprsented By The Department Of Health And Human Services Isolation of amplified genes via cDNA subtractive hybridization
GB9618050D0 (en) 1996-08-29 1996-10-09 Cancer Res Campaign Tech Global amplification of nucleic acids
US5846721A (en) 1996-09-19 1998-12-08 The Trustees Of Columbia University In The City Of New York Efficient and simpler method to construct normalized cDNA libraries with improved representations of full-length cDNAs
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
CA2284481A1 (en) 1997-03-24 1998-10-01 Smithkline Beecham Corporation Method of producing a subtraction library
US6399334B1 (en) 1997-09-24 2002-06-04 Invitrogen Corporation Normalized nucleic acid libraries and methods of production thereof
EP1032705B1 (en) 1997-10-30 2011-12-14 Cold Spring Harbor Laboratory Probe arrays and methods of using probe arrays for distinguishing dna
US5882874A (en) 1998-02-27 1999-03-16 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display

Also Published As

Publication number Publication date
ES2296623T3 (es) 2008-05-01
NO330813B1 (no) 2011-07-25
US20020051970A1 (en) 2002-05-02
ATE382097T1 (de) 2008-01-15
CA2372698C (en) 2010-04-27
JP2002543856A (ja) 2002-12-24
CY1107428T1 (el) 2012-12-19
DK1185699T3 (da) 2008-04-28
ZA200109609B (en) 2003-04-30
NO20015635D0 (no) 2001-11-19
IL146547A (en) 2008-04-13
WO2000070098A1 (en) 2000-11-23
PT1185699E (pt) 2008-02-26
EP1185699A1 (en) 2002-03-13
MXPA01011730A (es) 2002-04-24
DE60037584T2 (de) 2009-01-08
US6638717B2 (en) 2003-10-28
DE60037584D1 (de) 2008-02-07
IL146547A0 (en) 2002-07-25
CA2372698A1 (en) 2000-11-23
AU5145500A (en) 2000-12-05
KR100733930B1 (ko) 2007-07-03
EP1185699B1 (en) 2007-12-26
JP4714883B2 (ja) 2011-06-29
KR20020008190A (ko) 2002-01-29
BR0011297A (pt) 2002-02-26
AU779901B2 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
NO20015635L (no) Mikroseriebasert subtraktiv hybridisering
US5780231A (en) DNA extension and analysis with rolling primers
Li et al. RASL‐seq for massively parallel and quantitative analysis of gene expression
Myllykangas et al. Overview of sequencing technology platforms
Matz et al. Different strategies of differential display: areas of application
Oberley et al. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays
US5962228A (en) DNA extension and analysis with rolling primers
AU4965499A (en) Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation
Raine et al. SPlinted Ligation Adapter Tagging (SPLAT), a novel library preparation method for whole genome bisulphite sequencing
KR100204360B1 (en) A method for identifying a polynucleotide molecule having a selected nucleic acid sequence from a library of random or semi-random polynucleotide molecules
Bai et al. Design and synthesis of a photocleavable biotinylated nucleotide for DNA analysis by mass spectrometry
WO2000040755A3 (en) Method for accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
ATE403747T1 (de) Verfahren zur amplifikation von signal- flankierenden sequenzen aus unbekannten, genomischen daten
GB2401433A (en) Methods of parallel gene cloning and analysis
CN108251503A (zh) 一种快速构建链特异性rna高通量测序文库的方法
JP2001521398A (ja) 性状検査用ｄｎａ
Akintunde et al. The evolution of next-generation sequencing technologies
CN110964794A (zh) 适用于dna编码化合物测序文库测序的引物
Veeranagouda et al. Transposon Insertion Site Sequencing (TIS‐Seq): An Efficient and High‐Throughput Method for Determining Transposon Insertion Site (s) and Their Relative Abundances in a PiggyBac Transposon Mutant Pool by Next‐Generation Sequencing
US6670120B1 (en) Categorising nucleic acid
Martinez et al. Pseudouridine site assignment by high-throughput in vitro RNA pseudouridylation and sequencing
CN112996925A (zh) 用于crispr的靶标无关的向导rna
EP4155416B1 (en) Method for obtaining spatial and sequencing information of m-rna from tissue
Fish et al. Transcriptome Analysis at the Single‐Cell Level Using SMART Technology

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees